{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:24:49Z","timestamp":1792427089974,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04495-z","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T10:01:02Z","timestamp":1756720862000},"page":"2507-2518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A randomized controlled trial comparing the efficacy of resveratrol combined with metformin versus resveratrol monotherapy in the management of polycystic ovary syndrome"],"prefix":"10.1007","volume":"399","author":[{"given":"Musarrat","family":"Zahra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"4495_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11154-019-09494-z","volume":"20","author":"S Asgary","year":"2019","unstructured":"Asgary S, Karimi R, Momtaz S et al (2019) Effect of resveratrol on metabolic syndrome components: a systematic review and meta-analysis. Rev Endocr Metab Disord 20:173\u2013186","journal-title":"Rev Endocr Metab Disord"},{"key":"4495_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.31083\/j.ceog5105126","volume":"51","author":"H Bai","year":"2024","unstructured":"Bai H, Ding H, Wang M (2024) Polycystic ovary syndrome (PCOS): symptoms, causes, and treatment. Clin Exp Obstet Gynecol 51:126. https:\/\/doi.org\/10.31083\/j.ceog5105126","journal-title":"Clin Exp Obstet Gynecol"},{"key":"4495_CR3","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1210\/jc.2016-1858","volume":"101","author":"B Banaszewska","year":"2016","unstructured":"Banaszewska B, Wroty\u0144ska-Barczy\u0144ska J, Spaczynski RZ et al (2016) Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 101:4322\u20134328","journal-title":"J Clin Endocrinol Metab"},{"key":"4495_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493\u2013506","journal-title":"Nat Rev Drug Discov"},{"key":"4495_CR5","first-page":"61","volume":"13","author":"F Bazarganipour","year":"2015","unstructured":"Bazarganipour F, Taghavi SA, Montazeri A et al (2015) The impact of polycystic ovary syndrome on the health-related quality of life: A systematic review and meta-analysis. Iran J Reprod Med 13:61\u201370","journal-title":"Iran J Reprod Med"},{"key":"4495_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13186","volume":"83","author":"S Brenjian","year":"2020","unstructured":"Brenjian S, Moini A, Yamini N et al (2020) Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers. Am J Reprod Immunol 83:e13186. https:\/\/doi.org\/10.1111\/aji.13186","journal-title":"Am J Reprod Immunol"},{"key":"4495_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1529231","author":"H Chang","year":"2025","unstructured":"Chang H, Shi B, Wang Y et al (2025) Effect and mechanism of resveratrol against polycystic ovary syndrome: a review. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2025.1529231","journal-title":"Front Endocrinol"},{"key":"4495_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083923","volume":"22","author":"SA Dabravolski","year":"2021","unstructured":"Dabravolski SA, Nikiforov NG, Eid AH et al (2021) Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. Int J Mol Sci 22:3923","journal-title":"Int J Mol Sci"},{"key":"4495_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","volume":"109","author":"A Dokras","year":"2018","unstructured":"Dokras A, Stener-Victorin E, Yildiz BO et al (2018) Androgen excess-polycystic ovary syndrome society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil Steril 109:888\u2013899","journal-title":"Fertil Steril"},{"key":"4495_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/dietetics1020008","volume":"1","author":"P Dubey","year":"2022","unstructured":"Dubey P, Shi T, Coltharp M, Reddy S (2022) Effects of resveratrol on metabolic, biochemical, and endocrine manifestations in polycystic ovary syndrome. Dietetics 1:66\u201377","journal-title":"Dietetics"},{"key":"4495_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1177\/1933719115570900","volume":"22","author":"M Ergenoglu","year":"2015","unstructured":"Ergenoglu M, Yildirim N, Yildirim AGS et al (2015) Effects of resveratrol on ovarian morphology, plasma anti-mullerian hormone, IGF-1 levels, and oxidative stress parameters in a rat model of polycystic ovary syndrome. Reprod Sci 22:942\u2013947. https:\/\/doi.org\/10.1177\/1933719115570900","journal-title":"Reprod Sci"},{"key":"4495_CR12","doi-asserted-by":"crossref","unstructured":"Fadlalmola HA, Elhusein AM, Al-Sayaghi KM et al (2023) Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials. Pan Afr Med J 44","DOI":"10.11604\/pamj.2023.44.134.32404"},{"key":"4495_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13048-018-0427-7","volume":"11","author":"S Furat Rencber","year":"2018","unstructured":"Furat Rencber S, Kurnaz Ozbek S, Eraldem\u0131r C et al (2018) Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. J Ovarian Res 11:55. https:\/\/doi.org\/10.1186\/s13048-018-0427-7","journal-title":"J Ovarian Res"},{"key":"4495_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13104-025-07202-6","volume":"18","author":"A Kheirollahi","year":"2025","unstructured":"Kheirollahi A, Hamidi H, Vatannejad A (2025) Distribution of polycystic ovary syndrome (PCOS) phenotypes in Iranian women: a cross-sectional study. BMC Res Notes 18:215. https:\/\/doi.org\/10.1186\/s13104-025-07202-6","journal-title":"BMC Res Notes"},{"key":"4495_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/antiox10010084","volume":"10","author":"EM Kratz","year":"2021","unstructured":"Kratz EM, Kokot I, Dymicka-Piekarska V, Piwowar A (2021) Sirtuins\u2014the new important players in women\u2019s gynecological health. Antioxidants 10:84","journal-title":"Antioxidants"},{"key":"4495_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100457","volume":"65","author":"A Liang","year":"2021","unstructured":"Liang A, Huang L, Liu H et al (2021) Resveratrol improves follicular development of PCOS rats by regulating the glycolytic pathway. Mol Nutr Food Res 65:2100457. https:\/\/doi.org\/10.1002\/mnfr.202100457","journal-title":"Mol Nutr Food Res"},{"key":"4495_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W et al (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106:6\u201315. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003","journal-title":"Fertil Steril"},{"key":"4495_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1701-2163(16)32915-2","volume":"30","author":"ME Lujan","year":"2008","unstructured":"Lujan ME, Chizen DR, Pierson RA (2008) Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC 30:671\u2013679. https:\/\/doi.org\/10.1016\/S1701-2163(16)32915-2","journal-title":"J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC"},{"key":"4495_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041667","volume":"22","author":"A Mancini","year":"2021","unstructured":"Mancini A, Bruno C, Vergani E et al (2021) Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights. Int J Mol Sci 22:1667. https:\/\/doi.org\/10.3390\/ijms22041667","journal-title":"Int J Mol Sci"},{"key":"4495_CR20","first-page":"139","volume":"85","author":"P Moghetti","year":"2000","unstructured":"Moghetti P, Castello R, Negri C et al (2000) Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85:139\u2013146","journal-title":"J Clin Endocrinol Metab"},{"key":"4495_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/nu10050655","volume":"10","author":"CA Polito","year":"2018","unstructured":"Polito CA, Cai Z-Y, Shi Y-L et al (2018) Association of tea consumption with risk of Alzheimer\u2019s disease and anti-beta-amyloid effects of tea. Nutrients 10:655","journal-title":"Nutrients"},{"key":"4495_CR22","doi-asserted-by":"publisher","first-page":"8275303","DOI":"10.1155\/2021\/8275303","volume":"2021","author":"M Safiah","year":"2021","unstructured":"Safiah M, Hyassat D, Khader Y et al (2021) Effect of metformin on anthropometric measurements and hormonal and biochemical profile in patients with prediabetes. J Diabetes Res 2021:8275303. https:\/\/doi.org\/10.1155\/2021\/8275303","journal-title":"J Diabetes Res"},{"key":"4495_CR23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/cen.13003","volume":"84","author":"M Samimi","year":"2016","unstructured":"Samimi M, Jamilian M, Ebrahimi FA et al (2016) Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 84:851\u2013857. https:\/\/doi.org\/10.1111\/cen.13003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4495_CR24","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1002\/j.2040-4603.2022.tb00215.x","volume":"12","author":"MSB Silva","year":"2022","unstructured":"Silva MSB, Campbell RE (2022) Polycystic ovary syndrome and the neuroendocrine consequences of androgen excess. Compr Physiol 12:3347\u20133369. https:\/\/doi.org\/10.1002\/j.2040-4603.2022.tb00215.x","journal-title":"Compr Physiol"},{"key":"4495_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12905-015-0272-4","volume":"15","author":"SA Taghavi","year":"2015","unstructured":"Taghavi SA, Bazarganipour F, Hugh-Jones S, Hosseini N (2015) Health-related quality of life in Iranian women with polycystic ovary syndrome: a qualitative study. BMC Womens Health 15:111. https:\/\/doi.org\/10.1186\/s12905-015-0272-4","journal-title":"BMC Womens Health"},{"key":"4495_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1530\/EJE-07-0294","volume":"157","author":"S Tan","year":"2007","unstructured":"Tan S, Hahn S, Benson S et al (2007) Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol 157:669\u2013676","journal-title":"Eur J Endocrinol"},{"key":"4495_CR27","doi-asserted-by":"crossref","unstructured":"Tang T, Lord JM, Norman RJ et al (2012) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev","DOI":"10.1002\/14651858.CD003053.pub5"},{"key":"4495_CR28","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF et al (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod Oxf Engl 33:1602\u20131618. https:\/\/doi.org\/10.1093\/humrep\/dey256","journal-title":"Hum Reprod Oxf Engl"},{"key":"4495_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","volume":"14","author":"S Timmers","year":"2011","unstructured":"Timmers S, Konings E, Bilet L et al (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14:612\u2013622","journal-title":"Cell Metab"},{"key":"4495_CR30","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.3390\/nu16172856","volume":"16","author":"VE Tseilikman","year":"2024","unstructured":"Tseilikman VE, Tseilikman OB, Yegorov ON et al (2024) Resveratrol: a multifaceted guardian against anxiety and stress disorders\u2014an overview of experimental evidence. Nutrients 16:2856","journal-title":"Nutrients"},{"key":"4495_CR31","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/antiox10111718","volume":"10","author":"X-L Xu","year":"2021","unstructured":"Xu X-L, Deng S-L, Lian Z-X, Yu K (2021) Resveratrol targets a variety of oncogenic and oncosuppressive signaling for ovarian cancer prevention and treatment. Antioxidants 10:1718","journal-title":"Antioxidants"},{"key":"4495_CR32","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167\u20131174. https:\/\/doi.org\/10.1172\/JCI13505","journal-title":"J Clin Invest"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04495-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:52:10Z","timestamp":1770882730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04495-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4495"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04495-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval was obtained from Khyber Medical University (Approval No. DIR\/KMU-EB\/IA\/000838) and its Advanced Study and Research Board (Approval No. DIR\/KMU-AS&RB\/IA\/001202).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"During the preparation of this work, the authors used ChatGPT to enhance readability, as they are not native English speakers. The content was thoroughly reviewed and edited, and the authors take full responsibility for the final version of the published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"We attest that the subjects in this trial have not concomitantly been involved in other randomized trials. Data regarding any of the subjects in the study has not been previously published. Data will be made available to the editors of the journal for review or query upon request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Attestation statement"}},{"value":"Data will be made available upon reasonable request to the corresponding author.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing statement"}},{"value":"We declare that the work described has not been published previously, that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright- holder.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Submission declaration and verification"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}